Molecule Details
| Drug(s) of This Target | ||||
|---|---|---|---|---|
| 1 | Recombinant tissue plasminogen activator | Drug Info | Phase 4 | Pulmonary thromboembolism |
| References | ||||
|---|---|---|---|---|
| Reference 1 | Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action. Mol Pharmacol. 2007 Aug;72(2):418-28. | |||